_version_ 1818446589231890432
author Florence Robert-Gangneux
Valeria Meroni
Damien Dupont
Françoise Botterel
José M. Aguado Garcia
Marie-Pierre Brenier-Pinchart
Isabelle Accoceberry
Hamdi Akan
Isabella Abbate
Katia Boggian
Fabrizio Bruschi
Jordi Carratalà
Miruna David
Lubos Drgona
Olgica Djurković-Djaković
Maria Carmen Farinas
Francesca Genco
Effrossyni Gkrania-Klotsas
Andreas H. Groll
Edward Guy
Cédric Hirzel
Nina Khanna
Özgür Kurt
Lia Monica Junie
Tiziana Lazzarotto
Oscar Len
Nicolas J. Mueller
Patricia Munoz
Zoi Dorothea Pana
Emmanuel Roilides
Tijana Stajner
Christian van Delden
Isabelle Villena
Hervé Pelloux
Oriol Manuel
author_facet Florence Robert-Gangneux
Valeria Meroni
Damien Dupont
Françoise Botterel
José M. Aguado Garcia
Marie-Pierre Brenier-Pinchart
Isabelle Accoceberry
Hamdi Akan
Isabella Abbate
Katia Boggian
Fabrizio Bruschi
Jordi Carratalà
Miruna David
Lubos Drgona
Olgica Djurković-Djaković
Maria Carmen Farinas
Francesca Genco
Effrossyni Gkrania-Klotsas
Andreas H. Groll
Edward Guy
Cédric Hirzel
Nina Khanna
Özgür Kurt
Lia Monica Junie
Tiziana Lazzarotto
Oscar Len
Nicolas J. Mueller
Patricia Munoz
Zoi Dorothea Pana
Emmanuel Roilides
Tijana Stajner
Christian van Delden
Isabelle Villena
Hervé Pelloux
Oriol Manuel
author_sort Florence Robert-Gangneux
collection DOAJ
description Transplantation activity is increasing, leading to a growing number of patients at risk for toxoplasmosis. We reviewed toxoplasmosis prevention practices, prevalence, and outcomes for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT; heart, kidney, or liver) patients in Europe. We collected electronic data on the transplant population and prevention guidelines/regulations and clinical data on toxoplasmosis cases diagnosed during 2010–2014. Serologic pretransplant screening of allo-hematopoietic stem cell donors was performed in 80% of countries, screening of organ donors in 100%. SOT recipients were systematically screened in 6 countries. Targeted anti-Toxoplasma chemoprophylaxis was heterogeneous. A total of 87 toxoplasmosis cases were recorded (58 allo-HSCTs, 29 SOTs). The 6-month survival rate was lower among Toxoplasma-seropositive recipients and among allo-hematopoietic stem cell and liver recipients. Chemoprophylaxis improved outcomes for SOT recipients. Toxoplasmosis remains associated with high mortality rates among transplant recipients. Guidelines are urgently needed to standardize prophylactic regimens and optimize patient management.
first_indexed 2024-12-14T19:50:07Z
format Article
id doaj.art-48df254cf5314a0aafcdd203224de6df
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-14T19:50:07Z
publishDate 2018-08-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-48df254cf5314a0aafcdd203224de6df2022-12-21T22:49:27ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592018-08-012481497150410.3201/eid2408.180045Toxoplasmosis in Transplant Recipients, Europe, 2010–2014Florence Robert-GangneuxValeria MeroniDamien DupontFrançoise BotterelJosé M. Aguado GarciaMarie-Pierre Brenier-PinchartIsabelle AccoceberryHamdi AkanIsabella AbbateKatia BoggianFabrizio BruschiJordi CarratalàMiruna DavidLubos DrgonaOlgica Djurković-DjakovićMaria Carmen FarinasFrancesca GencoEffrossyni Gkrania-KlotsasAndreas H. GrollEdward GuyCédric HirzelNina KhannaÖzgür KurtLia Monica JunieTiziana LazzarottoOscar LenNicolas J. MuellerPatricia MunozZoi Dorothea PanaEmmanuel RoilidesTijana StajnerChristian van DeldenIsabelle VillenaHervé PellouxOriol ManuelTransplantation activity is increasing, leading to a growing number of patients at risk for toxoplasmosis. We reviewed toxoplasmosis prevention practices, prevalence, and outcomes for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT; heart, kidney, or liver) patients in Europe. We collected electronic data on the transplant population and prevention guidelines/regulations and clinical data on toxoplasmosis cases diagnosed during 2010–2014. Serologic pretransplant screening of allo-hematopoietic stem cell donors was performed in 80% of countries, screening of organ donors in 100%. SOT recipients were systematically screened in 6 countries. Targeted anti-Toxoplasma chemoprophylaxis was heterogeneous. A total of 87 toxoplasmosis cases were recorded (58 allo-HSCTs, 29 SOTs). The 6-month survival rate was lower among Toxoplasma-seropositive recipients and among allo-hematopoietic stem cell and liver recipients. Chemoprophylaxis improved outcomes for SOT recipients. Toxoplasmosis remains associated with high mortality rates among transplant recipients. Guidelines are urgently needed to standardize prophylactic regimens and optimize patient management.https://wwwnc.cdc.gov/eid/article/24/8/18-0045_articletoxoplasma infectiontransplantationtransplant recipientcerebral toxoplasmosishematopoietic stem cell transplantchemoprophylaxis
spellingShingle Florence Robert-Gangneux
Valeria Meroni
Damien Dupont
Françoise Botterel
José M. Aguado Garcia
Marie-Pierre Brenier-Pinchart
Isabelle Accoceberry
Hamdi Akan
Isabella Abbate
Katia Boggian
Fabrizio Bruschi
Jordi Carratalà
Miruna David
Lubos Drgona
Olgica Djurković-Djaković
Maria Carmen Farinas
Francesca Genco
Effrossyni Gkrania-Klotsas
Andreas H. Groll
Edward Guy
Cédric Hirzel
Nina Khanna
Özgür Kurt
Lia Monica Junie
Tiziana Lazzarotto
Oscar Len
Nicolas J. Mueller
Patricia Munoz
Zoi Dorothea Pana
Emmanuel Roilides
Tijana Stajner
Christian van Delden
Isabelle Villena
Hervé Pelloux
Oriol Manuel
Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
Emerging Infectious Diseases
toxoplasma infection
transplantation
transplant recipient
cerebral toxoplasmosis
hematopoietic stem cell transplant
chemoprophylaxis
title Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
title_full Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
title_fullStr Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
title_full_unstemmed Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
title_short Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
title_sort toxoplasmosis in transplant recipients europe 2010 2014
topic toxoplasma infection
transplantation
transplant recipient
cerebral toxoplasmosis
hematopoietic stem cell transplant
chemoprophylaxis
url https://wwwnc.cdc.gov/eid/article/24/8/18-0045_article
work_keys_str_mv AT florencerobertgangneux toxoplasmosisintransplantrecipientseurope20102014
AT valeriameroni toxoplasmosisintransplantrecipientseurope20102014
AT damiendupont toxoplasmosisintransplantrecipientseurope20102014
AT francoisebotterel toxoplasmosisintransplantrecipientseurope20102014
AT josemaguadogarcia toxoplasmosisintransplantrecipientseurope20102014
AT mariepierrebrenierpinchart toxoplasmosisintransplantrecipientseurope20102014
AT isabelleaccoceberry toxoplasmosisintransplantrecipientseurope20102014
AT hamdiakan toxoplasmosisintransplantrecipientseurope20102014
AT isabellaabbate toxoplasmosisintransplantrecipientseurope20102014
AT katiaboggian toxoplasmosisintransplantrecipientseurope20102014
AT fabriziobruschi toxoplasmosisintransplantrecipientseurope20102014
AT jordicarratala toxoplasmosisintransplantrecipientseurope20102014
AT mirunadavid toxoplasmosisintransplantrecipientseurope20102014
AT lubosdrgona toxoplasmosisintransplantrecipientseurope20102014
AT olgicadjurkovicdjakovic toxoplasmosisintransplantrecipientseurope20102014
AT mariacarmenfarinas toxoplasmosisintransplantrecipientseurope20102014
AT francescagenco toxoplasmosisintransplantrecipientseurope20102014
AT effrossynigkraniaklotsas toxoplasmosisintransplantrecipientseurope20102014
AT andreashgroll toxoplasmosisintransplantrecipientseurope20102014
AT edwardguy toxoplasmosisintransplantrecipientseurope20102014
AT cedrichirzel toxoplasmosisintransplantrecipientseurope20102014
AT ninakhanna toxoplasmosisintransplantrecipientseurope20102014
AT ozgurkurt toxoplasmosisintransplantrecipientseurope20102014
AT liamonicajunie toxoplasmosisintransplantrecipientseurope20102014
AT tizianalazzarotto toxoplasmosisintransplantrecipientseurope20102014
AT oscarlen toxoplasmosisintransplantrecipientseurope20102014
AT nicolasjmueller toxoplasmosisintransplantrecipientseurope20102014
AT patriciamunoz toxoplasmosisintransplantrecipientseurope20102014
AT zoidorotheapana toxoplasmosisintransplantrecipientseurope20102014
AT emmanuelroilides toxoplasmosisintransplantrecipientseurope20102014
AT tijanastajner toxoplasmosisintransplantrecipientseurope20102014
AT christianvandelden toxoplasmosisintransplantrecipientseurope20102014
AT isabellevillena toxoplasmosisintransplantrecipientseurope20102014
AT hervepelloux toxoplasmosisintransplantrecipientseurope20102014
AT oriolmanuel toxoplasmosisintransplantrecipientseurope20102014